A highly sensitive and selective viral protein detection method based on RNA oligonucleotide nanoparticle

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 323-329

  Roh, Changhyun ^a   Lee, Ho Young ^b   Kim, Sang Eun ^b   Jo, Sung Kee ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Biochip; Hepatitis C virus; Quantum dots; RNA oligonucleotide; Viral protein

Indexed keywords

AMINE; CARBOXYL GROUP; NANOPARTICLE; NONSTRUCTURAL PROTEIN 5B; OLIGONUCLEOTIDE; QUANTUM DOT; RNA OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN V;

5' UNTRANSLATED REGION; ARTICLE; BIOCHIP; COVALENT BOND; HEPATITIS C VIRUS; NONHUMAN; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS;

EID: 77951199572     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s10134     Document Type: Article

References (30)

1. Weiss U. Hepatitis. Nature. 2005;436:929.
2. Jameel S, Siddiqui A, Hu KQ. The molecular biology of hepatitis virus. In: Gitnick G, editor. Principles and Practice of Gastroenterology and Hepatology. New York, NY: Elsevier; 1994. p. 743-757.
3. Pawlotsky JM. Hepatitis C virus population dynamics during infection. Curr Top Microbiol Immunol. 2006;299:261-284.
4. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol. 2000;242:55-84.
5. De Francesco R, Tomei L, Altamura S, et al. Approaching a new era for hepatitis C virus therapy: Inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res. 2003;58:1-16.
6. Behrens SE, Tomei L, De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 1996;15:12-22.
7. Adachi T, Ago H, Habuka N, et al. The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymerase. Biochim Biophys Acta. 2002;1601:38-48.
8. Ferrari E, Wright-Minogue J, Fang JW, et al. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol. 1999;73:1649-1654.
9. Yamashita T, Kaneko S, Shirota Y, et al. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J Biol Chem. 1998;273:15479-15486.
10. Ishii K, Tanaka Y, Yap CC, et al. Expression of hepatitis C virus NS5B protein: Characterization of its RNA polymerase activity and RNA binding. Hepatology. 1999;29:1227-1235.
11. Ago H, Adachi T, Yoshida A, et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure. 1999;7: 1417-14126.
12. Bressanelli S, Tomei L, Roussel A, et al. Crystal structure of the RNA- dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci USA. 1999; 96:13034-13039.
13. Lohmann V, Overton H, Bartenschlager R. Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP. J Biol Chem. 1999;274:10807-10815.
14. Dhanak D, Duffy KJ, Johnston VK, et al. Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem. 2002;277:38322-38327.
15. Neerja KB, Alain BW, Tanaji TT, et al. Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Nucl Acids Res. 2008;36:1482-1496.
16. Cullen BR. Immunology. Outwitted by viral RNAs. Science. 2007; 317:329-330.
17. Griffin J, Singh AK, Senapati D, et al. Size- and distance-dependent nanoparticle surface-energy transfer (NSET) method for selective sensing of hepatitis C virus RNA. Chemistry. 2009;15:342-351.
18. Gaudy C, Thevenas C, Tichet J, et al. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J Clin Microbiol. 2005;43:1722-1726.
19. Alivisatos P. The use of nanocrystals in biological detection. Nat Biotechnol. 2004;22:47-52.
20. Fortina P, Kricka LJ, Surrey S, et al. Nanobiotechnology: The promise and reality of new approaches to molecular recognition. Trends Biotechnol. 2005;23:168-173.
21. Pinaud F, King D, Moore HP, et al. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J Am Chem Soc. 2004;126:6115-6123.
22. Biju V, Itoh T, Anas A, et al. Semiconductor quantum dots and metal nanoparticles: Syntheses, optical properties, and biological applications. Anal Bioanal Chem. 2008;391:2469-2495.
23. Ghasemi Y, Peymani P, Afifi S. Quantum dot: Magic nanoparticle for imaging, detection and targeting. Acta Biomed. 2009;80:156-165.
24. Jun T, Bochu W, Liancai Z. Quantum Dots: A novel tool to discovery. Pak J Biol Sci. 2006;9:917-922.
25. William WY, Chang E, Drezek R, et al. Water-soluble quantum dots for biomedical applications. Biochem Biophys Res Comm. 2006;348:781-786.
26. Medintz IL, Mattoussi H, Clapp AR. Potential clinical applications of quantum dots. Int J Nanomedicine. 2008;3:151-167.
27. Schröter S, Feucht M, Zöllner B, et al. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J Clin Microbiol. 2001;39:3056-3059.
28. Bartolomé J, López-Alcorocho JM, Castillo I, et al. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol. 2007;81:7710-7715.
29. Riccardi CS, Dahmouche K, Santilli CV, et al. Immobilization of streptavidin in sol-gel films: Application on the diagnosis of hepatitis C virus. Talanta. 2006;70:637-643.
30. Riccardi CS, Kranz C, Kowalik J, et al. Label-free DNA detection of hepatitis C virus based on modified conducting polypyrrole films at microelectrodes and atomic force microscopy Tip-integrated electrodes. Anal Chem. 2008;80:237-245.